T47D/iRFP stable cell line

T47D/iRFP cells are derived from the human breast cancer T47D cell line by stably integration of a constitutive miRFP670 stably expression construct. The T47D cell line represents luminal A subtype (ER+, PR±, HER2-) of breast cancer, making them a model for studying hormone receptor signaling and elucidating the progesterone-specific effects of a luminal A subtype of breast cancer. T47D/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.